Home » Topics » BioWorld Science

BioWorld Science
RSS

Chengdu Huajian Future Technology patents IDO1 inhibitors

July 16, 2019

Synlogic reports topline data from phase I/IIa study of SYNB-1618 in patients with PKU

July 16, 2019

Arbutus reports preliminary phase Ia/Ib data on oral HBV capsid inhibitor AB-506

July 16, 2019

Sosei and Genentech enter GPCR-focused research collaboration and license agreement

July 16, 2019

New public-private partnership to support phase III trial of Janssen's mosaic-based HIV vaccine

July 16, 2019

NSI-189 shows promise in murine models of Alzheimer's disease

July 16, 2019

Inscopix and Biogen announce research collaboration targeting chronic pain

July 16, 2019

FLVCR1 predicts poor outcome in esophageal squamous cell carcinoma

July 16, 2019

AVROBIO announces first kidney biopsy results and additional data for AVR-RD-01

July 16, 2019

Activity maintained for recombinant factor VIII modified to extend half-life: MG-1121

July 16, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 8, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...